Question 1

What is Abbott Laboratories's P/FCF ratio?

Accepted Answer

Abbott Laboratories (ABT) P/FCF ratio is 21.6× as of June 5, 2026. The ratio is calculated by dividing market capitalisation by trailing twelve-month free cash flow, using USD-normalised financials (IAS 21 exchange-rate translation for non-USD reporters).

Question 2

How is the P/FCF ratio calculated?

Accepted Answer

P/FCF = Market Capitalisation ÷ Trailing Twelve-Month (TTM) Free Cash Flow, where Free Cash Flow = Operating Cash Flow − Capital Expenditures. All inputs are sourced from audited GAAP/IFRS filings and translated to USD using period-end exchange rates so the multiple is comparable across companies and currencies.

Question 3

What is the P/FCF ratio?

Accepted Answer

The price-to-free-cash-flow (P/FCF) ratio compares a company's market capitalisation to its trailing twelve-month (TTM) free cash flow. It is calculated as market cap ÷ TTM free cash flow, where free cash flow = operating cash flow − capital expenditures. Because FCF cannot be inflated by non-cash accounting items, P/FCF is often considered a cleaner measure of "earnings-power valuation" than P/E — especially for capital-intensive businesses where depreciation diverges from real cash outflows.

Question 4

What is a good P/FCF ratio for Abbott Laboratories?

Accepted Answer

Mature companies that consistently convert profit into cash often trade at 15–25× P/FCF; capital-intensive businesses with lumpy capex typically trade lower. Compare against sector peers and against the company's own multi-year average — single-year P/FCF can be distorted by working-capital swings. For Abbott Laboratories specifically, the relevant sector benchmark is the current sector median of 19.8×.

Question 5

Is Abbott Laboratories's P/FCF ratio high or low?

Accepted Answer

Abbott Laboratories's P/FCF ratio of 21.6× is below its own 5-year average of 29.6× and above the sector median of 19.8×. That places the current reading at the 6th percentile of its 10-year history. A higher multiple usually reflects stronger expected growth, lower perceived risk, or higher returns on capital; a lower multiple reflects the opposite.

Question 6

What is Abbott Laboratories's historical P/FCF ratio range?

Accepted Answer

In the available daily series, Abbott Laboratories (ABT) P/FCF ratio has ranged from a low of 4.5× in 2011 to a high of 44.6× in 2024. The 5-year average is 29.6× and the 5-year median is 30.0×.

Question 7

What was Abbott Laboratories's P/FCF ratio in 2025?

Accepted Answer

Abbott Laboratories (ABT) P/FCF ratio at the end of 2025 was 29.6×. Annual values reflect the multiple on the last trading day of each calendar year, using the trailing twelve-month free cash flow figure available at that date.

Question 8

Why does Abbott Laboratories's P/FCF ratio change over time?

Accepted Answer

Valuation multiples move with two inputs: the numerator (market capitalisation, which tracks the share price) and the denominator (free cash flow). Share-price changes — driven by interest rates, earnings expectations, risk appetite, and broader market sentiment — typically dominate short-term moves, while changes in the underlying fundamental drive the longer-term trend. As a result, the ratio can rise during stock-price rallies even if the business itself has not become more valuable, and fall during sell-offs even when fundamentals are improving.


2025	$218.88B	$7.39B	29.6×	-1.2×	Dec 31, 2025
2024	$195.87B	$6.35B	30.8×	-6.9×	Dec 31, 2024
2023	$190.87B	$5.06B	37.7×	+13.3×	Dec 31, 2023
2022	$190.79B	$7.80B	24.4×	-4.3×	Dec 31, 2022
2021	$248.28B	$8.65B	28.7×	-5.2×	Dec 31, 2021
2020	$193.93B	$5.72B	33.9×	-0.2×	Dec 31, 2020
2019	$153.09B	$4.50B	34.0×	+8.2×	Dec 31, 2019
2018	$126.98B	$4.91B	25.9×	+3.4×	Dec 31, 2018
2017	$99.51B	$4.43B	22.4×	-4.7×	Dec 31, 2017
2016	$56.57B	$2.08B	27.2×	-8.5×	Dec 31, 2016
2015	$66.14B	$1.86B	35.6×	+9.5×	Dec 31, 2015
2014	$67.89B	$2.60B	26.1×	-1.1×	Dec 31, 2014
2013	$59.34B	$2.18B	27.2×	+20.7×	Dec 31, 2013
2012	$48.85B	$7.52B	6.5×	+0.8×	Dec 31, 2012
2011	$42.32B	$7.48B	5.7×	+1.0×	Dec 31, 2011
2010	$35.62B	$7.72B	4.6×	-1.8×	Dec 31, 2010
2009	$39.87B	$6.19B	6.4×	-0.1×	Dec 31, 2009
2008	$39.46B	$6.06B	6.5×	-5.2×	Dec 31, 2008
2007	$41.47B	$3.53B	11.8×	+2.8×	Dec 31, 2007
2006	$35.89B	$3.99B	9.0×	+1.7×	Dec 31, 2006
2005	$28.85B	$3.97B	7.3×	-3.9×	Dec 31, 2005
2004	$34.74B	$3.12B	11.1×	-1.9×	Dec 31, 2004
2003	$32.73B	$2.50B	13.1×	+3.4×	Dec 31, 2003
2002	$28.09B	$2.89B	9.7×	-6.5×	Dec 31, 2002
2001	$39.05B	$2.40B	16.3×	—	Dec 31, 2001


Align Technology (ALGN)	17.8×
McKesson (MCK)	17.8×
Gilead Sciences (GILD)	16.9×
DexCom (DXCM)	16.9×
Pfizer (PFE)	16.7×
Humana (HUM)	16.4×
Quest Diagnostics (DGX)	16.3×
Labcorp Holdings (LH)	15.9×
Becton, Dickinson and (BDX)	14.0×
HCA Healthcare (HCA)	13.5×
Incyte (INCY)	12.9×
UnitedHealth Group (UNH)	12.5×
CVS Health (CVS)	12.4×
Universal Health Services (UHS)	12.2×
Baxter International (BAX)	12.1×
Cardinal Health (CAH)	11.3×
IQVIA (IQV)	10.7×
Bristol-Myers Squibb (BMY)	10.4×
Biogen (BIIB)	10.3×
Elevance Health (ELV)	10.0×
Zimmer Biomet Holdings (ZBH)	9.6×
Cigna (CI)	9.1×
Viatris (VTRS)	9.1×
DaVita (DVA)	6.9×
Centene (CNC)	2.5×

P/FCF Ratio for Abbott Laboratories (ABT)

P/FCF Ratio daily chart for Abbott Laboratories (ABT)

Historical P/FCF Ratio for Abbott Laboratories (ABT) from 2001 to 2025

About P/FCF Ratio at Abbott Laboratories (ABT)

Abbott Laboratories P/FCF Ratio by Year

Abbott Laboratories P/FCF Ratio 2025: 29.6×

Abbott Laboratories P/FCF Ratio 2024: 30.8×

Abbott Laboratories P/FCF Ratio 2023: 37.7×

Abbott Laboratories P/FCF Ratio 2022: 24.4×

Abbott Laboratories P/FCF Ratio 2021: 28.7×

Sector peers by P/FCF Ratio — chart

Sector peers by P/FCF Ratio — table

Frequently asked questions

Abbott Laboratories (ABT) Key Financials

P/FCF Ratio daily chart for Abbott Laboratories (ABT)

Historical P/FCF Ratio for Abbott Laboratories (ABT) from 2001 to 2025

About P/FCF Ratio at Abbott Laboratories (ABT)

Abbott Laboratories P/FCF Ratio by Year

Abbott Laboratories P/FCF Ratio 2025: 29.6×

Abbott Laboratories P/FCF Ratio 2024: 30.8×

Abbott Laboratories P/FCF Ratio 2023: 37.7×

Abbott Laboratories P/FCF Ratio 2022: 24.4×

Abbott Laboratories P/FCF Ratio 2021: 28.7×

Sector peers by P/FCF Ratio — chart

Sector peers by P/FCF Ratio — table

Frequently asked questions

+What is Abbott Laboratories's P/FCF ratio?

+How is the P/FCF ratio calculated?

+What is the P/FCF ratio?

+What is a good P/FCF ratio for Abbott Laboratories?

+Is Abbott Laboratories's P/FCF ratio high or low?

+What is Abbott Laboratories's historical P/FCF ratio range?

+What was Abbott Laboratories's P/FCF ratio in 2025?

+Why does Abbott Laboratories's P/FCF ratio change over time?

Abbott Laboratories (ABT) Key Financials